The clinical accurate localization of Salvianolic Acids for Injection in the treatment of ischemic cerebrovascular disease inacute stage - a multi-center, single-arm, open clinical protocol.

Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1.Ischemic stroke onset in the preceding 72 hours
•2.National Institutes of Health Stroke Scale 6 to 20(including the boundary value)
•3.Males and females aged 18 years or older
•4.First onset or historical stroke without sequela and mRS score <= 1
•5.Sign the informed consent.

•1. Cranial imaging confirmed brain tumor, encephalitis, brain abscess and other diseases with similar symptoms, or confirmed hemorrhagic cerebral infarction, epidural hematoma, intracranial hematoma, ventricular hemorrhage, subarachnoid hemorrhage. 2. Severe disturbance of consciousness(NIHSS Ia >=2)3.Allergic to the drug ingredients used in the study. 4. Patients with severe primary diseases of heart, liver, kidney, blood and endocrine system. 5. Pregnant and lactating women. 6. Drug or alcohol abuser. 7. Mentally ill. 8. Participants who are participating in or have participated in other clinical trials within a month. 9. The researchers did not consider the selected subjects appropriate.

发起方

Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine